
Product Overview
KAVALIV-450SR is a hepatoprotective medication used to treat and manage various liver and gallbladder conditions. It contains Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid that helps dissolve cholesterol-rich gallstones and improves bile flow, protecting liver cells from damage caused by toxic bile acids. The Sustained Release (SR) formula ensures a steady release of the medication for long-lasting efficacy.
Key Ingredient
-
Ursodeoxycholic Acid (450mg): Works by reducing the amount of cholesterol produced by the liver and absorbed by the intestines, while also protecting liver tissue from inflammation.
Key Therapeutic Indications
KAVALIV-450SR is highly effective in the following conditions:
-
Primary Biliary Cholangitis (PBC): A chronic liver disease where the bile ducts in the liver are slowly destroyed.
-
Dissolution of Gallstones: Specifically for small to medium-sized radiolucent gallstones in patients who cannot undergo surgery.
-
Non-Alcoholic Fatty Liver Disease (NAFLD): Helps improve liver enzyme levels and reduces oxidative stress.
-
Alcoholic Liver Disease: Aids in the recovery and protection of liver cells.
-
Cystic Fibrosis-related Liver Disease: Improves bile secretion in affected patients.
Product Specifications
| Feature | Details |
| Brand Name | KAVALIV-450SR |
| Manufacturer | KAVAMED |
| Active Ingredient | Ursodeoxycholic Acid |
| Dosage Strength | 450 mg |
| Form | Sustained Release Tablets |
| Packaging | 10 x 10 Tablets (Blister/Strip) |



